These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2724644)

  • 21. Long-term treatment of Parkinson's disease with levodopa and other adjunctive drugs.
    Mizuno Y; Shimoda S; Origasa H
    J Neural Transm (Vienna); 2018 Jan; 125(1):35-43. PubMed ID: 28091751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Amphetamines in the treatment of Parkinson's disease.
    Parkes JD; Tarsy D; Marsden CD; Bovill KT; Phipps JA; Rose P; Asselman P
    J Neurol Neurosurg Psychiatry; 1975 Mar; 38(3):232-7. PubMed ID: 1097600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.
    Bejjani BP; Gervais D; Arnulf I; Papadopoulos S; Demeret S; Bonnet AM; Cornu P; Damier P; Agid Y
    J Neurol Neurosurg Psychiatry; 2000 May; 68(5):595-600. PubMed ID: 10766889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Levodopa as a single treatment of Parkinsonism. Long-term control of 24 cases with discrimination analysis].
    Borromei A; Manzini A
    Minerva Med; 1974 Nov; 65(79):4160-70. PubMed ID: 4610450
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical course of patients with idiopathic Parkinson's disease.
    Roos RA; Jongen JC; van der Velde EA
    Mov Disord; 1996 May; 11(3):236-42. PubMed ID: 8723138
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of the type, duration, severity and levodopa treatment of Parkinson's disease on cardiovascular autonomic responses.
    Mesec A; Sega S; Kiauta T
    Clin Auton Res; 1993 Oct; 3(5):339-44. PubMed ID: 8124067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug therapy for Parkinson's disease.
    Charles PD; Davis TL
    South Med J; 1996 Sep; 89(9):851-6. PubMed ID: 8790306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does Late Levodopa Administration Delay the Development of Dyskinesia in Patients with De Novo Parkinson's Disease?
    Chung SJ; Yoo HS; Lee HS; Jeong HE; Kim SJ; Oh JS; Kim JS; Sohn YH; Lee PH
    CNS Drugs; 2018 Oct; 32(10):971-979. PubMed ID: 30027399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk factors for peak dose dyskinesia in 100 levodopa-treated parkinsonian patients.
    Blanchet PJ; Allard P; Grégoire L; Tardif F; Bédard PJ
    Can J Neurol Sci; 1996 Aug; 23(3):189-93. PubMed ID: 8862840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Piribedil in the treatment of Parkinson disease (author's transl)].
    Nardini M; Sciannandrone R; Fieschi C; De Simone G
    Riv Patol Nerv Ment; 1975; 96(2):103-10. PubMed ID: 778998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F; Battaglia A; Chouza C; Dupont E; Gershanik O; Marti Masso JF; Montastruc JL;
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of Parkinson's disease with multiple drugs].
    Kuno S
    Nihon Rinsho; 1997 Jan; 55(1):59-64. PubMed ID: 9014424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A-56-year-old woman with parkinsonism, whose mother had Parkinson's disease].
    Shimo Y; Takanashi M; Ohta S; Terashima K; Mori H; Shirai T; Miwa H; Mizuno Y
    No To Shinkei; 2001 May; 53(5):495-505. PubMed ID: 11428377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    Stocchi F; Rabey JM
    Eur J Neurol; 2011 Dec; 18(12):1373-8. PubMed ID: 21895884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term effect of initiating pramipexole vs levodopa in early Parkinson disease.
    Parkinson Study Group CALM Cohort Investigators
    Arch Neurol; 2009 May; 66(5):563-70. PubMed ID: 19433655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr.
    Lees AJ; Tolosa E; Olanow CW
    Mov Disord; 2015 Jan; 30(1):19-36. PubMed ID: 25488030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Perioperative management of a patient with Parkinson's disease with intravenous infusion of levodopa].
    Mizuno J; Kato S; Watada M; Morita S
    Masui; 2009 Oct; 58(10):1286-9. PubMed ID: 19860235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-frequency stimulation of the globus pallidus internalis in Parkinson's disease: a study of seven cases.
    Gross C; Rougier A; Guehl D; Boraud T; Julien J; Bioulac B
    J Neurosurg; 1997 Oct; 87(4):491-8. PubMed ID: 9322838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nationwide multicenter prospective study on the long-term effects of bromocriptine for Parkinson's disease. Final report of a ten-year follow-up.
    Ogawa N; Kanazawa I; Kowa H; Kuno S; Mizuno Y; Tashiro K; Yanagisawa N
    Eur Neurol; 1997; 38 Suppl 2():37-49. PubMed ID: 9387802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progression of Parkinson's disease following thalamic deep brain stimulation for tremor.
    Tarsy D; Scollins L; Corapi K; O'Herron S; Apetauerova D; Norregaard T
    Stereotact Funct Neurosurg; 2005; 83(5-6):222-7. PubMed ID: 16534254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.